The discovery of molecules that can treat AD has been challenging, but compounds that are able to interfere with the transformation process, which is catalyzed by prionogenic seeding by tau fibrils, could be a promising prophylactic or therapeutic strategy for neurodegenerative diseases. This evidence concerns the gene MAPT and Alzheimer disease.